Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Histiocytoma, Malignant Fibrous × Dacarbazine × 1 year × Clear all

Sponsor

Conditions

Hodgkin Disease 16 Melanoma 6 Sarcoma 3 Neoplasms 2 Lymphoma 2 Leiomyosarcoma 2 Uveal Melanoma 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Lung Neoplasms 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Kidney Neoplasms 1 Immunotherapy 1 Hyperthermia 1 Colonic Neoplasms 1 Breast Neoplasms 1 Advanced Melanoma 1

Interventions

pembrolizumab 4 Specimen Handling 3 Doxorubicin 3 Radiotherapy 2 Radiation 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 CTLA-4 Antigen 2 Biopsy 2 tremelimumab 1 talimogene laherparepvec 1 regorafenib 1 pazopanib 1 olaratumab 1 futibatinib 1 fludarabine 1 eribulin 1 durvalumab 1 cabozantinib 1 avelumab 1 aldesleukin 1 X-Rays 1 Trabectedin 1 Standard of Care 1 Quality of Life 1 Immune Checkpoint Inhibitors 1 Ifosfamide 1 Histamine H2 Antagonists 1 Famotidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡